Login

Financial Snapshot

Revenue
TTM
$419.7M
Gross Margin
TTM
61.59%
Net Income
TTM
-$15.10M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
187.73%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$1.017B
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$69.25M

Stock Price

Loading...
Market Cap: $874.28 Million

About Certara Inc

Certara Inc (NASDAQ: CERT) is a biosimulation and drug development software company that provides model-informed drug development platforms and regulatory science services to pharmaceutical, biotechnology, and medical device companies. The filing excerpts provided do not contain sufficient detail to fully characterize revenue streams, segment splits, customer counts, geographic mix, or competitive positioning from the FY2025 10-K filed 2026-02-26. Based solely on the available filing text, specific financial metrics, product names, customer concentration figures, and competitor names cannot be confirmed and are therefore omitted per source-grounding requirements.

Source: SEC 10-K, filed 2026-02-26

Industry: Services-Prepackaged Software Peers: Veradigm Inc. Claritev Corp Definitive Healthcare Corp Evolent Health Inc GoodRx Holdings Inc Schrodinger Inc Teladoc Health Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support